Viewing Study NCT06747169


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-02 @ 3:43 AM
Study NCT ID: NCT06747169
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-12-27
First Post: 2024-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Sponsor: Jian-Guo Zhou, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module